
 
 
 
   Follicular lymphoma (FL)  is the most common indolent non-Hodgkin lymphoma, compromising approximately  20% of cases . The condition is characterized by neoplastic germinal center B cells. In approximately  90% of cases , neoplastic B cells harbor the t(14;18) (q32;q21) IGH/BCL2 translocation. This  translocation   the genetic hallmark of FL  is caused by disruption of V(D)J recombination in the bone marrow, resulting in overexpression of BCL2. 
 Are you up to date on the management of FL with progression? Test your knowledge with this quick quiz. 
 
 
 
 Question 1 /5 
 
 
 
 
 Which is an important predictor of outcomes in FL? 
 
 
 
 
 
 
 
 
 
 
 
 
 Progression or relapse within 2 years after diagnosis
                     
 
 
 
 
 
 
 
 
 
 
 
 
 Development of cytopenia during the watch-and-wait period 
 
 
 
 
 
 
 
 
 
 
 
 
 Development of bulky disease during the watch-and-wait period
                     
 
 
 
 
 
 
 
 
 
 
 
 
 Progression or relapse after immunochemotherapy 
 
 
 
   
 
 
                Submit & Proceed
             
 
 
 
 
 
 
 
 
 
 
 
 BACK NEXT 
 
 0 READ COMMENT 
 
 
 
 Medscape2021WebMD, LLC   
 Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape. 
 
 
 Cite this: Emmanuel C. Besa.Fast Five Quiz: Progression of Follicular Lymphoma- Medscape -Nov10,2021. 
 
 TOP PICKS FOR YOU 
 
 
 
 
 
 
 
